Heading To The Set-Up

For a while, it looked like the last update’s conclusions were incorrect; that biotech (XBI), was not going to make it to up-thrust condition.

Then, we had Friday’s action, a textbook reversal bar.

So, now, it looks like there’s potential to get back on track to the target area (not advice, not a recommendation).

Biotech XBI, Daily

Price action penetrated support, XBI is now in ‘spring position’.

After Friday’s downswing for the overall markets, there could be some upside bias early in the week (not advice, not a recommendation).

Stay Tuned

Charts by StockCharts

Note:  Posts on this site are for education purposes only.  They provide one firm’s insight on the markets.  Not investment advice.  See additional disclaimer here.

The Danger Point®, trade mark: No. 6,505,279